This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Showing all 30 results
The recent BIND Webinar brought together patients, caregivers, and researchers with a shared interest in advancing our understanding of brain…
Monthly #apaperaday wrap-up: September 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of September 2024.
BIND Webinar: Understanding the role of dystrophin in the brain
We are inviting you to join the BIND Patient Community Webinar, taking place on Monday, September 23 at 18:00 CEST.…
Monthly #apaperaday wrap-up: August 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of August 2024.
Monthly #apaperaday wrap-up: July 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of July 2024.
Givinostat – How does it work and what do we know so far for Duchenne?
By Prof Annemieke Aartsma-Rus. This version was generated on July 8, 2024. Givinostat has been approved for the treatment of…
Monthly #apaperaday wrap-up: June 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of June 2024.
Monthly #apaperaday wrap-up: May 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of May 2024.
Monthly #apaperaday wrap-up: April 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of April 2024.
Monthly #apaperaday wrap-up: March 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of March 2024.
Monthly #apaperaday wrap-up: February 2024
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of February 2024.
How the VISION of DMD patients helped the development of a new steroid
Approval of AGAMREE® The approval of AGAMREE®, (formerly known as vamorolone) on Monday 18 December by the European Medicines Agency for the treatment…
Monthly #apaperaday wrap-up: May 2023
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of May 2023.
Monthly #apaperaday wrap-up: April 2023
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of April 2023.
Monthly #apaperaday wrap-up: March 2023
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of March 2023.
Monthly #apaperaday wrap-up: February 2023
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of February 2023.
Monthly #apaperaday wrap-up: January 2023
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of January 2023.
Monthly #apaperaday wrap-up: December 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of December 2022.
Monthly #apaperaday wrap-up: November 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of November 2022.
Monthly #apaperaday wrap-up: October 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of October 2022.
#apaperaday special: Cause of manifesting Duchenne carriers
Dilated cardiomyopathy is frequent in manifesting Duchenne carriers. Also, women can be a carrier if they don't have a relative with Duchenne.
#apaperaday special: Cardiac Care for Female Carriers of Duchenne
Cardiac Care for Female Carriers of Duchenne: 2/3 mothers with a child with Duchenne is at risk of developing dilated cardiomyopathy.
#apaperaday special: Duchenne in a female
Duchenne in a female: Authors report a girl who at 5 years of age showed all the signs and symptoms of Duchenne.
Monthly #apaperaday wrap-up: June 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of June 2022.
Monthly #apaperaday wrap-up: May 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of May 2022.
Monthly #apaperaday wrap-up: April 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of April 2022.
Monthly #apaperaday wrap-up: March 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of March 2022.
Monthly #apaperaday wrap-up: February 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of February 2022.
Research Summary: Italian Conference on Duchenne and Becker Muscular Dystrophy
Prof. Aartsma-Rus’ personal highlights of the 2022 International Conference on Duchenne and Becker Muscular Dystrophy research updates.
Monthly #apaperaday wrap-up: January 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of January 2022.